Conzzeta has sold Schmid Rhyner to Altana
With Schmid Rhyner, Altana acquires the global innovation leader in UV-curing and specialty packaging coating solutions. As part of Altana’s flexible packaging coatings division ACTEGA, Schmid Rhyner will ideally complement ACTEGA’s globally leading product offering. With joined forces, ACTEGA and Schmid Rhyner will be able to serve the combined customer base with a comprehensive portfolio of highly innovative UV-curing, water-based as well as further specialty (e.g. dual cure formulations) products and solutions on a global scale.
ACTEGA intends to continue production of Schmid Rhyner’s products at its current facility in Adliswil, Switzerland.
For Conzzeta, the transaction is an important first successful step in its recently announced strategy to streamline its business portfolio and to focus on its Bystronic business unit.
Lincoln International acted as the exclusive M&A adviser to Conzzeta, providing process, financial and tactical advisory expertise and managing the preparatory, marketing, due diligence and negotiation phases of the transaction.
The transaction, which is Lincoln International’s 20th Chemicals deal globally in the last twelve months and the fifth coatings deal in Switzerland alone, further demonstrates the firm’s leading sell-side track record in chemicals, coatings and corporate disposals.
Terms of the agreement were not disclosed. Closing of the transaction is expected by the end of the first quarter 2020, subject to regulatory approval.
Meet our Senior Team

I enjoy leading clients and realizing their objectives, while structuring solutions to issues that are both intriguing and challenging.
Øyvind Bjordal
Managing Director | Head of Switzerland
ZurichView More Transactions in Chemicals
Perspectives

Chemicals Quarterly Review Q3 2023
The economy exhibited modest growth over the summer, both fueling concerns about a potential recession and nurturing hopes that it might be averted. After two consecutive quarters of contraction, the… Read More

Chemicals Quarterly Review Q2 2023
Equities rallied in Q2 2023, with the S&P 500 gaining 16.9% year-to-date through June, driven primarily by artificial intelligence (AI)-fueled enthusiasm for large-cap technology stocks. The chemicals sector has been… Read More

Chemicals Quarterly Review Q1 2023
A growing push and pull demand for biobased chemical intermediate solutions will drive further mergers and acquisitions (M&A) activity. There is an ever increasing emphasis for more environmental, social and… Read More

Specialty Chemicals: The Story of the Specialty Transformation
The specialty chemicals equity story is becoming increasingly important as the historical diversification benefit of more traditional commodity chemicals players – or even the diversified chemical conglomerates of yore –… Read More
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.